BioXcel Therapeutics (BTAI)
BioXcel Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
6.1M
Short interest
settlement 2026-08-31
1.0
Days to cover
-3.2 days vs prior
63.3%
Short share of volume
2026-09-04
1,927,474
Fails to deliver
settlement 2026-09-08
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-08.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 31 August 2026, short interest in BTAI is 6,124,886 shares, up 1,909,966 shares over the last month. Over the last 48 readings it ranged from 74,295 shares (15 April 2025) to 6,124,886 shares (31 August 2026). The latest reading sits at the top of that range. At the reported average volume of 7.2M shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/btai" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 6,124,886 | +84.8% | 7,193,434 | 1.00 |
| 2026-08-14 | 3,314,382 | -21.4% | 797,377 | 4.16 |
| 2026-07-31 | 4,214,920 | +4.2% | 435,332 | 9.68 |
| 2026-07-15 | 4,043,653 | +10.4% | 2,461,749 | 1.64 |
| 2026-06-30 | 3,662,908 | -15.1% | 619,033 | 5.92 |
| 2026-06-15 | 4,315,372 | +22.4% | 629,684 | 6.85 |
| 2026-05-29 | 3,525,975 | -0.8% | 788,205 | 4.47 |
| 2026-05-15 | 3,555,157 | -16.2% | 627,747 | 5.66 |
| 2026-04-30 | 4,243,441 | +7.5% | 887,591 | 4.78 |
| 2026-04-15 | 3,946,749 | +19.2% | 1,280,233 | 3.08 |
| 2026-03-31 | 3,312,077 | +18.1% | 723,648 | 4.58 |
| 2026-03-13 | 2,804,918 | +49.5% | 5,379,473 | 1.00 |
| 2026-02-27 | 1,876,148 | -3.2% | 251,580 | 7.46 |
| 2026-02-13 | 1,937,441 | +26.9% | 345,278 | 5.61 |
| 2026-01-30 | 1,527,067 | +11.8% | 563,033 | 2.71 |
| 2026-01-15 | 1,365,977 | +32.6% | 715,027 | 1.91 |
| 2025-12-31 | 1,030,339 | +5.2% | 459,736 | 2.24 |
| 2025-12-15 | 979,751 | +7.7% | 478,100 | 2.05 |
| 2025-11-28 | 909,508 | -42.5% | 681,331 | 1.33 |
| 2025-11-14 | 1,580,569 | +12.7% | 714,036 | 2.21 |
| 2025-10-31 | 1,402,142 | +22.9% | 788,261 | 1.78 |
| 2025-10-15 | 1,141,061 | -28.2% | 1,233,294 | 1.00 |
| 2025-09-30 | 1,590,112 | +10.2% | 1,397,117 | 1.14 |
| 2025-09-15 | 1,443,374 | -64.3% | 2,699,036 | 1.00 |
| 2025-08-29 | 4,045,812 | +166.7% | 11,593,771 | 1.00 |
| 2025-08-15 | 1,517,065 | +471.4% | 40,817,401 | 1.00 |
| 2025-07-31 | 265,503 | -24.6% | 316,466 | 1.00 |
| 2025-07-15 | 352,193 | +4.7% | 354,060 | 1.00 |
| 2025-06-30 | 336,411 | +5.9% | 374,244 | 1.00 |
| 2025-06-13 | 317,641 | -38.4% | 214,158 | 1.48 |
| 2025-05-30 | 515,650 | +285.4% | 681,675 | 1.00 |
| 2025-05-15 | 133,793 | +52.1% | 118,449 | 1.13 |
| 2025-04-30 | 87,945 | +18.4% | 68,309 | 1.29 |
| 2025-04-15 | 74,295 | -66.6% | 124,781 | 1.00 |
| 2025-03-31 | 222,659 | +0.6% | 639,162 | 1.00 |
| 2025-03-14 | 221,319 | -33.0% | 16,606,829 | 1.00 |
| 2025-02-28 | 330,479 | +16.1% | 11,482,880 | 1.00 |
| 2025-02-14 | 284,534 | -92.9% | 253,173 | 1.12 |
| 2025-01-31 | 4,011,254 | +151.1% | 4,126,758 | 1.00 |
| 2025-01-15 | 1,597,465 | +97.8% | 1,628,600 | 1.00 |
| 2024-12-31 | 807,677 | -23.4% | 1,111,103 | 1.00 |
| 2024-12-13 | 1,054,013 | +17.3% | 849,700 | 1.24 |
| 2024-11-29 | 898,726 | +44.0% | 810,821 | 1.11 |
| 2024-11-15 | 624,143 | +79.8% | 499,392 | 1.25 |
| 2024-10-31 | 347,081 | -39.8% | 348,390 | 1.00 |
| 2024-10-15 | 576,411 | +11.6% | 370,857 | 1.55 |
| 2024-09-30 | 516,384 | -26.0% | 900,096 | 1.00 |
| 2024-09-13 | 697,630 | +2.5% | 402,544 | 1.73 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 4 September 2026, the short share of BTAI volume is 63.3%, up 2.0 points over the last five sessions. Over the last 30 readings it ranged from 38.3% (5 August 2026) to 79.8% (20 August 2026). The latest reading is 8.3 points above the 30-session average of 55.0%, on 15.7M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-04 | 9.9M | 15.7M | 63.3% | 2,270,742 |
| 2026-09-03 | 10.9M | 19.5M | 56.0% | 1,823,645 |
| 2026-09-02 | 16.5M | 31.6M | 52.1% | 3,162,714 |
| 2026-09-01 | 4.5M | 8.6M | 51.9% | 1,135,604 |
| 2026-08-31 | 2.7M | 5.5M | 49.6% | 637,687 |
| 2026-08-28 | 17.5M | 28.6M | 61.3% | 3,337,868 |
| 2026-08-27 | 489K | 713K | 68.5% | 3,697 |
| 2026-08-26 | 309K | 593K | 52.1% | 0 |
| 2026-08-25 | 634K | 903K | 70.3% | 0 |
| 2026-08-24 | 413K | 560K | 73.8% | 2,000 |
| 2026-08-21 | 208K | 385K | 54.0% | 0 |
| 2026-08-20 | 321K | 402K | 79.8% | 39 |
| 2026-08-19 | 196K | 428K | 45.7% | 28,164 |
| 2026-08-18 | 516K | 732K | 70.4% | 44,909 |
| 2026-08-17 | 741K | 1.2M | 60.0% | 163,901 |
| 2026-08-14 | 512K | 1.0M | 51.0% | 67,484 |
| 2026-08-13 | 275K | 566K | 48.6% | 25 |
| 2026-08-12 | 340K | 746K | 45.7% | 900 |
| 2026-08-11 | 177K | 432K | 40.9% | 5,100 |
| 2026-08-10 | 120K | 282K | 42.6% | 0 |
| 2026-08-07 | 136K | 275K | 49.4% | 100 |
| 2026-08-06 | 138K | 234K | 59.0% | 0 |
| 2026-08-05 | 69K | 181K | 38.3% | 0 |
| 2026-08-04 | 101K | 239K | 42.4% | 0 |
| 2026-08-03 | 212K | 487K | 43.6% | 12,454 |
| 2026-07-31 | 198K | 332K | 59.6% | 0 |
| 2026-07-30 | 253K | 469K | 53.9% | 0 |
| 2026-07-29 | 118K | 226K | 52.1% | 0 |
| 2026-07-28 | 131K | 186K | 70.5% | 850 |
| 2026-07-27 | 63K | 143K | 43.7% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 September 2026, the fails-to-deliver balance in BTAI is 1,927,474 shares, up 1,276,674 shares over the last settlement date. Over the last 30 readings it ranged from 310 shares (5 August 2026) to 1,927,474 shares (8 September 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-08 | 1,927,474 | $0.07 | $135K |
| 2026-09-04 | 650,800 | $0.12 | $78K |
| 2026-09-03 | 786,744 | $0.11 | $87K |
| 2026-09-02 | 94,563 | $0.14 | $13K |
| 2026-09-01 | 47,424 | $0.16 | $8K |
| 2026-08-31 | 656,894 | $0.18 | $118K |
| 2026-08-28 | 5,252 | $0.72 | $4K |
| 2026-08-27 | 552 | $0.78 | $431 |
| 2026-08-26 | 72,810 | $0.74 | $54K |
| 2026-08-24 | 85,553 | $0.80 | $68K |
| 2026-08-21 | 25,831 | $0.80 | $21K |
| 2026-08-20 | 870 | $0.83 | $722 |
| 2026-08-18 | 13,785 | $0.89 | $12K |
| 2026-08-12 | 188,116 | $0.93 | $175K |
| 2026-08-11 | 33,185 | $0.93 | $31K |
| 2026-08-07 | 1,133 | $0.83 | $940 |
| 2026-08-05 | 310 | $0.86 | $267 |
| 2026-08-04 | 983 | $0.85 | $836 |
| 2026-08-03 | 3,004 | $0.81 | $2K |
| 2026-07-24 | 43,705 | $0.87 | $38K |
| 2026-07-15 | 6,749 | $1.03 | $7K |
| 2026-07-14 | 2,049 | $0.88 | $2K |
| 2026-07-13 | 24,680 | $0.82 | $20K |
| 2026-07-09 | 1,154 | $0.80 | $923 |
| 2026-07-08 | 70,278 | $1.04 | $73K |
| 2026-07-07 | 16,003 | $1.10 | $18K |
| 2026-07-06 | 397 | $1.38 | $548 |
| 2026-07-01 | 4,487 | $1.41 | $6K |
| 2026-06-30 | 1,873 | $1.40 | $3K |
| 2026-06-24 | 2,153 | $1.26 | $3K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BTAI in the last 90 days. The most recent filings are listed below. Latest filing: Mehta Vimal (CEO and President) on 2026-06-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mehta Vimal | CEO and President | Exercise or conversion | 219 | price not stated in the filing | not stated | 70K |
| 2026-06-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 26K |
| 2026-06-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 26K |
| 2026-06-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 35 | price not stated in the filing | not stated | 27K |
| 2026-05-20 | Mehta Vimal | CEO and President | Sell | 19K | $1.09 | $21K | 70K |
| 2026-05-20 | Steinhart Richard I | Chief Financial Officer | Sell | 7K | $1.09 | $7K | 26K |
| 2026-05-20 | Rodriguez Javier | See Remarks | Sell | 7K | $1.08 | $7K | 27K |
| 2026-05-20 | Yocca Frank | Chief Scientific Officer | Sell | 7K | $1.09 | $7K | 26K |
| 2026-05-04 | Mehta Vimal | CEO and President | Exercise or conversion | 50K | price not stated in the filing | not stated | 89K |
| 2026-05-04 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 18K | price not stated in the filing | not stated | 33K |
| 2026-05-04 | Rodriguez Javier | See Remarks | Exercise or conversion | 18K | price not stated in the filing | not stated | 33K |
| 2026-05-04 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 18K | price not stated in the filing | not stated | 33K |
| 2026-05-01 | Rodriguez Javier | See Remarks | Exercise or conversion | 9K | price not stated in the filing | not stated | 16K |
| 2026-05-01 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 9K | price not stated in the filing | not stated | 16K |
| 2026-05-01 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 9K | price not stated in the filing | not stated | 16K |
| 2026-05-01 | Mehta Vimal | CEO and President | Exercise or conversion | 18K | price not stated in the filing | not stated | 39K |
| 2026-03-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2026-03-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2026-03-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2026-03-15 | Mehta Vimal | CEO and President | Exercise or conversion | 219 | price not stated in the filing | not stated | 21K |
| 2026-03-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 6K |
| 2026-03-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 33 | price not stated in the filing | not stated | 7K |
| 2026-03-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 7K |
| 2026-03-14 | Mehta Vimal | CEO and President | Exercise or conversion | 164 | price not stated in the filing | not stated | 21K |
| 2025-12-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 6K |
| 2025-12-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2025-12-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2025-12-15 | Mehta Vimal | CEO and President | Exercise or conversion | 219 | price not stated in the filing | not stated | 21K |
| 2025-12-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 6K |
| 2025-12-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 33 | price not stated in the filing | not stated | 7K |
| 2025-12-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 7K |
| 2025-12-14 | Mehta Vimal | CEO and President | Exercise or conversion | 164 | price not stated in the filing | not stated | 21K |
| 2025-10-31 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 20K |
| 2025-09-30 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 19K |
| 2025-09-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 6K |
| 2025-09-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2025-09-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 7K |
| 2025-09-15 | Mehta Vimal | CEO and President | Exercise or conversion | 219 | price not stated in the filing | not stated | 20K |
| 2025-09-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 6K |
| 2025-09-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 33 | price not stated in the filing | not stated | 7K |
| 2025-09-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 6K |
| 2025-09-14 | Mehta Vimal | CEO and President | Exercise or conversion | 163 | price not stated in the filing | not stated | 20K |
| 2025-08-31 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 17K |
| 2025-07-31 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 15K |
| 2025-07-22 | Rodriguez Javier | See Remarks | Grant | 4K | price not stated in the filing | not stated | 6K |
| 2025-07-22 | Rodriguez Javier | See Remarks | Exercise or conversion | 625 | price not stated in the filing | not stated | 7K |
| 2025-07-22 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 625 | price not stated in the filing | not stated | 6K |
| 2025-07-22 | Steinhart Richard I | Chief Financial Officer | Grant | 4K | price not stated in the filing | not stated | 6K |
| 2025-07-22 | Yocca Frank | Chief Scientific Officer | Grant | 4K | price not stated in the filing | not stated | 6K |
| 2025-07-22 | Mehta Vimal | CEO and President | Grant | 16K | price not stated in the filing | not stated | 20K |
| 2025-06-30 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 14K |
| 2025-06-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 35 | price not stated in the filing | not stated | 2K |
| 2025-06-15 | Mehta Vimal | CEO and President | Exercise or conversion | 219 | price not stated in the filing | not stated | 4K |
| 2025-06-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 2K |
| 2025-06-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 35 | price not stated in the filing | not stated | 1K |
| 2025-06-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 33 | price not stated in the filing | not stated | 2K |
| 2025-06-14 | Mehta Vimal | CEO and President | Exercise or conversion | 163 | price not stated in the filing | not stated | 4K |
| 2025-06-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 2K |
| 2025-06-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 33 | price not stated in the filing | not stated | 1K |
| 2025-05-31 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 12K |
| 2025-04-30 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 10K |
| 2025-03-31 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 8K |
| 2025-03-15 | Mehta Vimal | CEO and President | Exercise or conversion | 217 | price not stated in the filing | not stated | 4K |
| 2025-03-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 34 | price not stated in the filing | not stated | 2K |
| 2025-03-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 34 | price not stated in the filing | not stated | 2K |
| 2025-03-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 34 | price not stated in the filing | not stated | 1K |
| 2025-03-14 | Mehta Vimal | CEO and President | Exercise or conversion | 162 | price not stated in the filing | not stated | 4K |
| 2025-03-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 31 | price not stated in the filing | not stated | 2K |
| 2025-03-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 31 | price not stated in the filing | not stated | 2K |
| 2025-03-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 31 | price not stated in the filing | not stated | 1K |
| 2025-02-28 | MACK DAVID J. | Director | Exercise or conversion | 2K | price not stated in the filing | not stated | 7K |
| 2025-01-31 | MACK DAVID J. | Director | Exercise or conversion | 27K | price not stated in the filing | not stated | 81K |
| 2024-12-31 | MACK DAVID J. | Director | Exercise or conversion | 27K | price not stated in the filing | not stated | 54K |
| 2024-12-16 | Yocca Frank | Chief Scientific Officer | Sell | 225 | $0.35 | $79 | 29K |
| 2024-12-16 | Yocca Frank | Chief Scientific Officer | Sell | 205 | $0.36 | $74 | 29K |
| 2024-12-16 | Rodriguez Javier | See Remarks | Sell | 210 | $0.36 | $76 | 25K |
| 2024-12-16 | Rodriguez Javier | See Remarks | Sell | 220 | $0.36 | $79 | 24K |
| 2024-12-16 | Steinhart Richard I | Chief Financial Officer | Sell | 372 | $0.36 | $134 | 21K |
| 2024-12-16 | Steinhart Richard I | Chief Financial Officer | Sell | 205 | $0.36 | $74 | 21K |
| 2024-12-16 | Mehta Vimal | CEO and President | Sell | 2K | $0.36 | $768 | 60K |
| 2024-12-16 | Mehta Vimal | CEO and President | Sell | 983 | $0.36 | $354 | 61K |
| 2024-12-16 | O'Neill Vincent | See Remarks | Sell | 165 | $0.35 | $58 | 20K |
| 2024-12-15 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 562 | price not stated in the filing | not stated | 29K |
| 2024-12-15 | Rodriguez Javier | See Remarks | Exercise or conversion | 562 | price not stated in the filing | not stated | 25K |
| 2024-12-15 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 562 | price not stated in the filing | not stated | 21K |
| 2024-12-15 | Mehta Vimal | CEO and President | Exercise or conversion | 4K | price not stated in the filing | not stated | 62K |
| 2024-12-14 | Yocca Frank | Chief Scientific Officer | Exercise or conversion | 521 | price not stated in the filing | not stated | 29K |
| 2024-12-14 | Rodriguez Javier | See Remarks | Exercise or conversion | 521 | price not stated in the filing | not stated | 24K |
| 2024-12-14 | Steinhart Richard I | Chief Financial Officer | Exercise or conversion | 521 | price not stated in the filing | not stated | 21K |
| 2024-12-14 | Mehta Vimal | CEO and President | Exercise or conversion | 3K | price not stated in the filing | not stated | 58K |
| 2024-12-14 | O'Neill Vincent | See Remarks | Exercise or conversion | 521 | price not stated in the filing | not stated | 20K |
| 2024-11-30 | MACK DAVID J. | Director | Exercise or conversion | 27K | price not stated in the filing | not stated | 27K |
| 2024-11-30 | MACK DAVID J. | Director | Exercise or conversion | 27K | price not stated in the filing | not stated | 27K |
| 2024-10-03 | O'Neill Vincent | See Remarks | Sell | 6K | $0.55 | $3K | 20K |
| 2024-10-03 | Steinhart Richard I | Chief Financial Officer | Sell | 7K | $0.55 | $4K | 20K |
| 2024-10-03 | Yocca Frank | Chief Scientific Officer | Sell | 7K | $0.55 | $4K | 28K |
| 2024-10-03 | Rodriguez Javier | See Remarks | Sell | 7K | $0.55 | $4K | 24K |
| 2024-10-03 | Wiley Matthew T. | Chief Commercial Officer | Sell | 6K | $0.55 | $3K | 19K |
| 2024-09-17 | O'Neill Vincent | See Remarks | Grant | 21K | price not stated in the filing | not stated | 25K |
| 2024-09-17 | Steinhart Richard I | Chief Financial Officer | Grant | 21K | price not stated in the filing | not stated | 27K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for BTAI worth $43K at the prices reported; 0 in the last 90 days worth $0. Latest: Mehta Vimal filed on 2026-05-20 to sell 19,419 shares ($21K) from 2026-05-20.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-05-20 | Mehta VimalOfficer | 19K | $21K | 0.063% | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Rodriguez JavierOfficer | 7K | $7K | 0.021% | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Yocca FrankOfficer | 7K | $7K | 0.022% | 2026-05-20 | Merrill Lynch |
| 2026-05-20 | Steinhart Richard IOfficer | 7K | $7K | 0.022% | 2026-05-20 | Merrill Lynch |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of BTAI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Integrated Core Strategies (US) LLC at 8.4% of the class (1,833,717 shares), filed 2026-02-09 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Armistice Capital, LLCinvestment adviser, other entity | 1.6M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Steven Boydparent holding company, individual | 1.6M | 5.0% | 2026-06-30 |
| 2026-03-30 | 13G/Ano. 1 | Qatar Investment Authorityother entity | 156K | 0.6% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 1 | Integrated Core Strategies (US) LLCother entity | 1.8M | 8.4% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 1 | Millennium Management LLCother entity | 1.8M | 8.4% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 1 | Millennium Group Management LLCother entity | 1.8M | 8.4% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 1 | Israel A. Englanderindividual | 1.8M | 8.4% | 2025-12-31 |
13F holders
Tracked managers holding BTAI at their latest 13F. JSON2 of the 30 tracked managers held BTAI at their latest 13F, $3.2M in total at quarter-end prices. Millennium Management is the largest at $3.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 2.1M | $3.0M | 0.00% | +178K |
| Citadel Advisors | 2026-06-30 | 149K | $210K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
BioXcel Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows BioXcel Therapeutics (BTAI), SEC CIK 1720893, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-09-04.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-08.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-05-20.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-15.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1720893Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of BTAI is sold short?
6,124,886 shares were held short at the 2026-08-31 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BTAI's daily short volume?
On 2026-09-04, 9,934,151 of the 15,698,223 BTAI shares reported to FINRA were sold short, 63.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BTAI have fails to deliver?
The SEC's latest file shows 1,927,474 BTAI shares failed to deliver at settlement 2026-09-08. Fails are reported per settlement date and published twice a month with a lag.
Are BTAI insiders buying or selling?
No open-market insider trades were reported for BTAI in the last 90 days. The most recent filings are listed below. Latest filing: Mehta Vimal (CEO and President) on 2026-06-15.
Have BTAI insiders filed to sell?
4 Form 144 notices on file for BTAI worth $43K at the prices reported; 0 in the last 90 days worth $0. Latest: Mehta Vimal filed on 2026-05-20 to sell 19,419 shares ($21K) from 2026-05-20.
Who owns 5% or more of BTAI?
4 holders report 5% or more of BTAI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Integrated Core Strategies (US) LLC at 8.4% of the class (1,833,717 shares), filed 2026-02-09 for an event on 2025-12-31.
Which tracked 13F managers own BTAI?
2 of the 30 tracked 13F managers held BTAI shares at their latest filing, $3.2M in all. The largest: Izzy Englander's Millennium Management (2.1M shares, $3.0M), Ken Griffin's Citadel Advisors (149K shares, $210K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.